Udaya Rangaswamy, Ph.D.Senior Scientist at Teneobio
Dr. Rangaswamy is a senior scientist at Teneobio, Inc., a company focused on discovery and development of novel multi-specific antibodies for cancer therapy. Dr. Rangaswamy is a project lead for several candidate multispecific antibodies in oncology. She also oversees strategy for optimization and selection of lead candidates for Teneobio’s therapeutic T cell bispecific antibody pipeline. Dr. Rangaswamy earned her PhD in Microbiology and Molecular Genetics at Emory University and was a post-doctoral fellow at MedImmune/Astrazeneca prior to joining Teneobio.